XTNT
Xtant Medical Holdings, Inc.
Price Chart
Latest Quote
$0.60
Current Price| Previous Close | $0.59 |
| Open | $0.59 |
| Day High | $0.62 |
| Day Low | $0.59 |
| Volume | 135,569 |
Stock Information
| Shares Outstanding | 140.00M |
| Total Debt | $32.49M |
| Cash Equivalents | $10.40M |
| Revenue | $133.08M |
| Net Income | $1.75M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $84.14M |
| P/E Ratio | 60.10 |
| EPS (TTM) | $0.01 |
| Exchange | ASE |
đ Custom Metrics & Score
Score: 14/42| Debt to Equity | 0.82 |
| Debt to Earnings | 0.52 |
| Current Ratio | 2.35 |
| Quick Ratio | 0.94 |
| Avg Revenue Growth | 28.05% |
| Profit Margin | -14.03% |
| Return on Equity | -38.29% |
| Avg FCF Growth | 213.80% |
| FCF Yield | -19.03% |
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-02-02 | $0.60 | 135,569 |
| 2026-01-30 | $0.59 | 181,800 |
| 2026-01-29 | $0.61 | 145,200 |
| 2026-01-28 | $0.62 | 148,300 |
| 2026-01-27 | $0.61 | 170,800 |
| 2026-01-26 | $0.64 | 232,400 |
| 2026-01-23 | $0.65 | 275,900 |
| 2026-01-22 | $0.62 | 253,200 |
| 2026-01-21 | $0.63 | 332,300 |
| 2026-01-20 | $0.65 | 170,000 |
| 2026-01-16 | $0.67 | 124,200 |
| 2026-01-15 | $0.65 | 261,100 |
| 2026-01-14 | $0.68 | 215,900 |
| 2026-01-13 | $0.70 | 93,100 |
| 2026-01-12 | $0.70 | 341,600 |
| 2026-01-09 | $0.68 | 135,700 |
| 2026-01-08 | $0.70 | 103,000 |
| 2026-01-07 | $0.72 | 130,200 |
| 2026-01-06 | $0.71 | 98,300 |
| 2026-01-05 | $0.71 | 284,900 |
About Xtant Medical Holdings, Inc.
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. The company offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, which can be compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also provides sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, the company offers cervical products comprising Spider cervical plating, Streamline OCT, and CervAlign systems; thoracolumbar products consisting of Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation, and HPS 2.0 hybrid performance systems; and Silex sacroiliac joint fusion systems. Further, it provides interbody products comprising Calix for cervical and thoracolumbar applications, Irix-C Cervical and Irix-A lumbar integrated dusion systems, and Fortilink implants; and interlaminar stabilization products, such as Coflex device for lumbar spinal stenosis; and CoFix implants for back and disc pain. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.
đ° Latest News
3 Promising Penny Stocks With Over $90M Market Cap
Simply Wall St. âĸ 2025-12-09T12:05:19Z
Xtant Medical Holdings Inc (XTNT) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ...
GuruFocus.com âĸ 2025-11-11T21:01:11ZOctober 2025's Spotlight On Promising Penny Stocks
Simply Wall St. âĸ 2025-10-14T12:05:13Z
Companion Spine to acquire Paradigm Spine assets from Xtant Medical
Medical Device Network âĸ 2025-07-09T11:28:57Z
US Penny Stocks: 3 Picks With Market Caps As Low As $70M
Simply Wall St. âĸ 2025-02-20T20:11:11Z
Income Statement (Annual)
Revenue
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Reconciled Cost Of Revenue | $49,051,000 | $35,836,000 | $25,832,000 | $22,773,000 |
| Cost Of Revenue | $49,051,000 | $35,836,000 | $25,832,000 | $22,773,000 |
| Total Revenue | $117,267,000 | $91,303,000 | $57,969,000 | $55,263,000 |
| Operating Revenue | $117,267,000 | $91,303,000 | $57,969,000 | $55,146,000 |
Expenses
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Interest Expense | $4,160,000 | $2,938,000 | $1,692,000 | $995,000 |
| Total Expenses | $129,341,000 | $101,461,000 | $64,724,000 | $59,117,000 |
| Other Income Expense | $-28,000 | $11,910,000 | - | - |
| Other Non Operating Income Expenses | $-33,000 | $-49,000 | - | - |
| Net Non Operating Interest Income Expense | $-4,160,000 | $-2,789,000 | $-1,661,000 | $-995,000 |
| Interest Expense Non Operating | $4,160,000 | $2,938,000 | $1,692,000 | $995,000 |
| Operating Expense | $80,290,000 | $65,625,000 | $38,892,000 | $36,344,000 |
| Selling And Marketing Expense | $49,214,000 | $38,439,000 | $22,515,000 | $21,025,000 |
| General And Administrative Expense | $28,691,000 | $25,850,000 | $15,462,000 | $14,449,000 |
Income & Earnings
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Income From Continuing Operation Net Minority Interest | $-16,449,000 | $660,000 | $-8,485,000 | $-4,849,000 |
| Net Interest Income | $-4,160,000 | $-2,789,000 | $-1,661,000 | $-995,000 |
| Interest Income | $0 | $149,000 | $31,000 | $0 |
| Normalized Income | $-16,452,950 | $-8,787,610 | $-8,485,000 | $-4,849,000 |
| Net Income From Continuing And Discontinued Operation | $-16,449,000 | $660,000 | $-8,485,000 | $-4,849,000 |
| Total Operating Income As Reported | $-12,074,000 | $-10,158,000 | $-6,755,000 | $-3,854,000 |
| Net Income Common Stockholders | $-16,449,000 | $660,000 | $-8,485,000 | $-4,849,000 |
| Net Income | $-16,449,000 | $660,000 | $-8,485,000 | $-4,849,000 |
| Net Income Including Noncontrolling Interests | $-16,449,000 | $660,000 | $-8,485,000 | $-4,849,000 |
| Net Income Continuous Operations | $-16,449,000 | $660,000 | $-8,485,000 | $-4,849,000 |
| Pretax Income | $-16,262,000 | $-1,037,000 | $-8,416,000 | $-4,849,000 |
| Special Income Charges | $0 | $11,694,000 | $0 | - |
| Interest Income Non Operating | $0 | $149,000 | $31,000 | $0 |
| Operating Income | $-12,074,000 | $-10,158,000 | $-6,755,000 | $-3,854,000 |
| Gross Profit | $68,216,000 | $55,467,000 | $32,137,000 | $32,490,000 |
Per Share Metrics
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Diluted EPS | $-0.12 | $0.01 | $-0.09 | $-0.06 |
| Basic EPS | $-0.12 | $0.01 | $-0.09 | $-0.06 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | $1,050 | $2,511,390 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-7,883,000 | $-6,884,000 | $-5,432,000 | $-2,522,000 |
| Total Unusual Items | $5,000 | $11,959,000 | $0 | - |
| Total Unusual Items Excluding Goodwill | $5,000 | $11,959,000 | $0 | - |
| Reconciled Depreciation | $4,224,000 | $3,174,000 | $1,292,000 | $1,332,000 |
| EBITDA (Bullshit earnings) | $-7,878,000 | $5,075,000 | $-5,432,000 | $-2,522,000 |
| EBIT | $-12,102,000 | $1,901,000 | $-6,724,000 | $-3,854,000 |
| Diluted Average Shares | $133,665,075 | $126,793,318 | $94,085,197 | $85,456,175 |
| Basic Average Shares | $133,665,075 | $119,093,687 | $94,085,197 | $85,456,175 |
| Diluted NI Availto Com Stockholders | $-16,449,000 | $660,000 | $-8,485,000 | $-4,849,000 |
| Tax Provision | $187,000 | $-1,697,000 | $69,000 | $0 |
| Restructuring And Mergern Acquisition | $0 | $-11,694,000 | $0 | - |
| Gain On Sale Of Security | $5,000 | $265,000 | - | - |
| Research And Development | $2,385,000 | $1,336,000 | $915,000 | $870,000 |
| Selling General And Administration | $77,905,000 | $64,289,000 | $37,977,000 | $35,474,000 |
| Other Gand A | $28,691,000 | $25,850,000 | $15,462,000 | $14,449,000 |
Balance Sheet (Annual)
Assets
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Tangible Assets | $27,305,000 | $33,962,000 | $30,622,000 | $27,278,000 |
| Total Assets | $93,837,000 | $92,612,000 | $60,229,000 | $54,692,000 |
| Total Non Current Assets | $26,721,000 | $27,743,000 | $10,911,000 | $10,362,000 |
| Other Non Current Assets | $103,000 | $141,000 | $197,000 | $287,000 |
| Goodwill And Other Intangible Assets | $15,658,000 | $17,387,000 | $3,549,000 | $3,605,000 |
| Other Intangible Assets | $8,356,000 | $10,085,000 | $344,000 | $400,000 |
| Current Assets | $67,116,000 | $64,869,000 | $49,318,000 | $44,330,000 |
| Other Current Assets | $1,601,000 | $1,330,000 | $673,000 | $844,000 |
| Restricted Cash | $22,000 | $208,000 | $209,000 | $144,000 |
| Inventory | $38,634,000 | $36,885,000 | $17,285,000 | $17,945,000 |
| Receivables | $20,660,000 | $20,731,000 | $10,853,000 | $7,154,000 |
| Accounts Receivable | $20,660,000 | $20,731,000 | $10,853,000 | $7,154,000 |
| Allowance For Doubtful Accounts Receivable | $-1,437,000 | $-920,000 | $-515,000 | $-552,000 |
| Gross Accounts Receivable | $22,097,000 | $21,651,000 | $11,368,000 | $7,706,000 |
| Cash Cash Equivalents And Short Term Investments | $6,199,000 | $5,715,000 | $20,298,000 | $18,243,000 |
| Cash And Cash Equivalents | $6,199,000 | $5,715,000 | $20,298,000 | $18,243,000 |
| Prepaid Assets | - | - | - | $844,000 |
Debt
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Debt | $27,959,000 | $16,074,000 | - | - |
| Total Debt | $35,143,000 | $23,559,000 | $17,072,000 | $16,845,000 |
| Long Term Debt And Capital Lease Obligation | $22,251,000 | $18,042,000 | $10,840,000 | $12,732,000 |
| Long Term Debt | $22,038,000 | $17,167,000 | $9,687,000 | $11,787,000 |
| Current Debt And Capital Lease Obligation | $12,892,000 | $5,517,000 | $6,232,000 | $4,113,000 |
| Current Debt | $12,120,000 | $4,622,000 | $5,712,000 | $3,620,000 |
| Other Current Borrowings | - | - | $2,333,000 | - |
Liabilities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Liabilities Net Minority Interest | $50,874,000 | $41,263,000 | $26,058,000 | $23,809,000 |
| Total Non Current Liabilities Net Minority Interest | $22,293,000 | $18,273,000 | $10,840,000 | $12,732,000 |
| Non Current Deferred Liabilities | $42,000 | $21,000 | $0 | - |
| Non Current Deferred Taxes Liabilities | $42,000 | $21,000 | $0 | - |
| Current Liabilities | $28,581,000 | $22,990,000 | $15,218,000 | $11,077,000 |
| Payables And Accrued Expenses | $15,689,000 | $17,473,000 | $8,986,000 | $6,964,000 |
| Payables | $13,483,000 | $15,944,000 | $7,954,000 | $5,799,000 |
| Other Payable | $5,565,000 | $8,890,000 | $4,464,000 | $3,184,000 |
| Accounts Payable | $7,918,000 | $7,054,000 | $3,490,000 | $2,615,000 |
Equity
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Common Stock Equity | $42,963,000 | $51,349,000 | $34,171,000 | $30,883,000 |
| Total Equity Gross Minority Interest | $42,963,000 | $51,349,000 | $34,171,000 | $30,883,000 |
| Stockholders Equity | $42,963,000 | $51,349,000 | $34,171,000 | $30,883,000 |
| Gains Losses Not Affecting Retained Earnings | $-316,000 | $29,000 | $0 | - |
| Other Equity Adjustments | $-316,000 | $29,000 | - | - |
| Retained Earnings | $-259,459,000 | $-243,010,000 | $-243,670,000 | $-235,185,000 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Ordinary Shares Number | $139,045,664 | $130,180,031 | $108,874,803 | $87,068,980 |
| Share Issued | $139,045,664 | $130,180,031 | $108,874,803 | $87,068,980 |
| Tangible Book Value | $27,305,000 | $33,962,000 | $30,622,000 | $27,278,000 |
| Invested Capital | $77,121,000 | $73,138,000 | $49,570,000 | $46,290,000 |
| Working Capital | $38,535,000 | $41,879,000 | $34,100,000 | $33,253,000 |
| Capital Lease Obligations | $985,000 | $1,770,000 | $1,673,000 | $1,438,000 |
| Total Capitalization | $65,001,000 | $68,516,000 | $43,858,000 | $42,670,000 |
| Additional Paid In Capital | $302,738,000 | $294,330,000 | $277,841,000 | $266,068,000 |
| Capital Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Non Current Accrued Expenses | $0 | $210,000 | $0 | - |
| Long Term Capital Lease Obligation | $213,000 | $875,000 | $1,153,000 | $945,000 |
| Current Capital Lease Obligation | $772,000 | $895,000 | $520,000 | $493,000 |
| Line Of Credit | $12,120,000 | $4,622,000 | $3,379,000 | $3,620,000 |
| Current Accrued Expenses | $2,206,000 | $1,529,000 | $1,032,000 | $1,165,000 |
| Goodwill | $7,302,000 | $7,302,000 | $3,205,000 | $3,205,000 |
| Net PPE | $10,960,000 | $10,215,000 | $7,165,000 | $6,470,000 |
| Accumulated Depreciation | $-19,837,000 | $-19,680,000 | $-17,964,000 | $-17,169,000 |
| Gross PPE | $30,797,000 | $29,895,000 | $25,129,000 | $23,639,000 |
| Leases | $4,356,000 | $4,347,000 | $4,105,000 | $3,849,000 |
| Other Properties | $24,826,000 | $23,988,000 | $19,751,000 | $18,549,000 |
| Machinery Furniture Equipment | $1,615,000 | $1,560,000 | $1,273,000 | $1,241,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $29,200,000 | $28,054,000 | $10,859,000 | $11,761,000 |
| Work In Process | $2,812,000 | $1,562,000 | $798,000 | $571,000 |
| Raw Materials | $6,622,000 | $7,269,000 | $5,628,000 | $5,613,000 |
Cash Flow Statement (Annual)
Free Cash Flow
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | $-16,009,000 | $-10,971,000 | $-7,105,000 | $-1,676,000 |
Operating Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Operating Cash Flow | $-11,896,000 | $-9,515,000 | $-5,341,000 | $439,000 |
| Cash Flow From Continuing Operating Activities | $-11,896,000 | $-9,515,000 | $-5,341,000 | $439,000 |
| Operating Gains Losses | $-264,000 | $-115,000 | $-93,000 | $-86,000 |
Investing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Capital Expenditure | $-4,113,000 | $-1,456,000 | $-1,764,000 | $-2,115,000 |
| Investing Cash Flow | $-3,730,000 | $-24,784,000 | $-1,559,000 | $-1,890,000 |
| Cash Flow From Continuing Investing Activities | $-3,730,000 | $-24,784,000 | $-1,559,000 | $-1,890,000 |
Financing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Issuance Of Capital Stock | $4,456,000 | $14,011,000 | $9,311,000 | $18,426,000 |
| Financing Cash Flow | $16,073,000 | $19,691,000 | $9,020,000 | $17,497,000 |
| Cash Flow From Continuing Financing Activities | $16,073,000 | $19,691,000 | $9,020,000 | $17,497,000 |
| Net Other Financing Charges | $-829,000 | $-500,000 | - | $-337,000 |
| Net Common Stock Issuance | $4,456,000 | $14,011,000 | $9,311,000 | $18,426,000 |
| Common Stock Issuance | $4,456,000 | $14,011,000 | $9,311,000 | $18,426,000 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Repayment Of Debt | $-105,207,000 | $-77,039,000 | $-54,520,000 | $-36,953,000 |
| Issuance Of Debt | $117,640,000 | $83,219,000 | $54,229,000 | $36,361,000 |
| Interest Paid Supplemental Data | $3,638,000 | $2,552,000 | $1,454,000 | $846,000 |
| End Cash Position | $6,221,000 | $5,923,000 | $20,507,000 | $18,387,000 |
| Beginning Cash Position | $5,923,000 | $20,507,000 | $18,387,000 | $2,341,000 |
| Effect Of Exchange Rate Changes | $-149,000 | $24,000 | $0 | - |
| Changes In Cash | $447,000 | $-14,608,000 | $2,120,000 | $16,046,000 |
| Proceeds From Stock Option Exercised | $13,000 | $0 | - | $0 |
| Net Issuance Payments Of Debt | $12,433,000 | $6,180,000 | $-291,000 | $-592,000 |
| Net Short Term Debt Issuance | $7,498,000 | $1,243,000 | $-241,000 | $-131,000 |
| Short Term Debt Payments | $-105,142,000 | $-76,976,000 | $-54,470,000 | $-36,492,000 |
| Short Term Debt Issuance | $112,640,000 | $78,219,000 | $54,229,000 | $36,361,000 |
| Net Long Term Debt Issuance | $4,935,000 | $4,937,000 | $-50,000 | $-461,000 |
| Long Term Debt Payments | $-65,000 | $-63,000 | $-50,000 | $-461,000 |
| Long Term Debt Issuance | $5,000,000 | $5,000,000 | $0 | - |
| Net Business Purchase And Sale | $0 | $-23,503,000 | $0 | - |
| Purchase Of Business | $0 | $-23,503,000 | $0 | - |
| Net PPE Purchase And Sale | $-3,730,000 | $-1,281,000 | $-1,559,000 | $-1,890,000 |
| Sale Of PPE | $383,000 | $175,000 | $205,000 | $225,000 |
| Purchase Of PPE | $-4,113,000 | $-1,456,000 | $-1,764,000 | $-2,115,000 |
| Change In Working Capital | $-5,349,000 | $-3,634,000 | $-2,811,000 | $793,000 |
| Change In Payables And Accrued Expense | $-1,882,000 | $6,768,000 | $2,021,000 | $-1,445,000 |
| Change In Accrued Expense | $-2,915,000 | $3,788,000 | $1,146,000 | $-1,113,000 |
| Change In Payable | $1,033,000 | $2,980,000 | $875,000 | $-332,000 |
| Change In Account Payable | $1,033,000 | $2,980,000 | $875,000 | $-332,000 |
| Change In Prepaid Assets | $-218,000 | $220,000 | $261,000 | $-67,000 |
| Change In Inventory | $-2,494,000 | $-1,886,000 | $-1,152,000 | $2,624,000 |
| Change In Receivables | $-755,000 | $-8,736,000 | $-3,941,000 | $-319,000 |
| Changes In Account Receivables | $-755,000 | $-8,736,000 | $-3,941,000 | $-319,000 |
| Other Non Cash Items | $496,000 | $-11,292,000 | $237,000 | $156,000 |
| Stock Based Compensation | $4,117,000 | $2,739,000 | $2,464,000 | $2,209,000 |
| Provisionand Write Offof Assets | $1,308,000 | $854,000 | $2,055,000 | $884,000 |
| Deferred Tax | $21,000 | $-1,901,000 | $0 | - |
| Deferred Income Tax | $21,000 | $-1,901,000 | $0 | - |
| Depreciation Amortization Depletion | $4,224,000 | $3,174,000 | $1,292,000 | $1,332,000 |
| Depreciation And Amortization | $4,224,000 | $3,174,000 | $1,292,000 | $1,332,000 |
| Gain Loss On Sale Of PPE | $-264,000 | $-115,000 | $-93,000 | $-86,000 |
| Net Income From Continuing Operations | $-16,449,000 | $660,000 | $-8,485,000 | $-4,849,000 |